275 related articles for article (PubMed ID: 22328068)
1. Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease.
Vaidya A; Forman JP
Curr Hypertens Rep; 2012 Apr; 14(2):111-9. PubMed ID: 22328068
[TBL] [Abstract][Full Text] [Related]
2. Vitamin d therapy and cardiovascular health.
Judd SE; Tangpricha V
Curr Hypertens Rep; 2011 Jun; 13(3):187-91. PubMed ID: 21298577
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status and arterial hypertension: a systematic review.
Pilz S; Tomaschitz A; Ritz E; Pieber TR
Nat Rev Cardiol; 2009 Oct; 6(10):621-30. PubMed ID: 19687790
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Vitamin D in the Treatment of Essential Hypertension.
Legarth C; Grimm D; Wehland M; Bauer J; Krüger M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401665
[TBL] [Abstract][Full Text] [Related]
6. The role of vitamin D in blood pressure, endothelial and renal function in postmenopausal women.
Liu ZM; Woo J; Wu SH; Ho SC
Nutrients; 2013 Jul; 5(7):2590-610. PubMed ID: 23839167
[TBL] [Abstract][Full Text] [Related]
7. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
[TBL] [Abstract][Full Text] [Related]
8. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial.
McMullan CJ; Borgi L; Curhan GC; Fisher N; Forman JP
J Hypertens; 2017 Apr; 35(4):822-829. PubMed ID: 28033130
[TBL] [Abstract][Full Text] [Related]
9. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
Carrara D; Bruno RM; Bacca A; Taddei S; Duranti E; Ghiadoni L; Bernini G
J Hypertens; 2016 Nov; 34(11):2199-205. PubMed ID: 27648718
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?
Lee JH; O'Keefe JH; Bell D; Hensrud DD; Holick MF
J Am Coll Cardiol; 2008 Dec; 52(24):1949-56. PubMed ID: 19055985
[TBL] [Abstract][Full Text] [Related]
11. Controversy in the link between vitamin D supplementation and hypertension.
Beveridge LA; Witham MD
Expert Rev Cardiovasc Ther; 2015; 13(9):971-3. PubMed ID: 26153248
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and cardiovascular diseases: Causality.
Wimalawansa SJ
J Steroid Biochem Mol Biol; 2018 Jan; 175():29-43. PubMed ID: 28027913
[TBL] [Abstract][Full Text] [Related]
13. Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.
Beveridge LA; Khan F; Struthers AD; Armitage J; Barchetta I; Bressendorff I; Cavallo MG; Clarke R; Dalan R; Dreyer G; Gepner AD; Forouhi NG; Harris RA; Hitman GA; Larsen T; Khadgawat R; Marckmann P; Mose FH; Pilz S; Scholze A; Shargorodsky M; Sokol SI; Stricker H; Zoccali C; Witham MD
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29848497
[TBL] [Abstract][Full Text] [Related]
14. [Vitamin D and kidney diseases].
Cavalier É; Thervet É; Courbebaisse M
Presse Med; 2013 Oct; 42(10):1391-7. PubMed ID: 24055557
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease.
Franczyk A; Stolarz-Skrzypek K; Wesołowska A; Czarnecka D
Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):34-44. PubMed ID: 24597598
[TBL] [Abstract][Full Text] [Related]
16. Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D.
Carrara D; Bernini M; Bacca A; Rugani I; Duranti E; Virdis A; Ghiadoni L; Taddei S; Bernini G
J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):82-7. PubMed ID: 23283825
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and Cardiovascular Disease: Controversy Unresolved.
Al Mheid I; Quyyumi AA
J Am Coll Cardiol; 2017 Jul; 70(1):89-100. PubMed ID: 28662812
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and cardiovascular disease.
Nemerovski CW; Dorsch MP; Simpson RU; Bone HG; Aaronson KD; Bleske BE
Pharmacotherapy; 2009 Jun; 29(6):691-708. PubMed ID: 19476421
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD
Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D therapy.
Geller JL; Adams JS
Curr Osteoporos Rep; 2008 Mar; 6(1):5-11. PubMed ID: 18430394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
